Article Information
History
- June 9, 2020.
Article Versions
- Version 1 (October 18, 2019 - 07:53).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Shengqing Gu1,2,10,*,
- Stephanie Lheureux1,3,
- Azin Sayad1,
- Paulina Cybulska1,4,11,
- Liat Ben-David Hogen1,4,
- Iryna Vyarvelska1,4,
- Dongsheng Tu5,
- Wendy Parulekar5,
- Matthew Nankivell6,
- Sean Kehoe7,
- Dennis Chi8,
- Douglas A. Levine9,
- Marcus Q. Bernardini1,4,
- Barry Rosen1,4,12,
- Amit Oza1,3 and
- Benjamin G. Neel1,2,13,*
- 1Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G2M9, Canada
- 2Department of Medical Biophysics, University of Toronto, Toronto, ON M5G1L7, Canada
- 3Division of Medical Oncology and Hematology, University of Toronto, Toronto, ON M5G2M9, Canada
- 4Division of Gynecologic Oncology, University of Toronto, Toronto, ON M5G2M9, Canada
- 5NCIC Clinical Trials Group, Queens University, Kingston, ON K7L3N6, Canada
- 6MRC Clinical Trials Unit, University College London, London, WC1V6LJ, UK
- 7Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B152TT, UK
- 8Memorial Sloan Kettering Cancer Center, NY 10065, USA
- 9Laura and Isaac Perlmutter Cancer Center, NYU-Langone Medical Center, NY 10016, USA
- ↵*Correspondence: Shengqing_gu{at}dfci.harvard.edu (S.G.), Benjamin.neel{at}nyumc.org (B.G.N.)